1. An innovative phase II trial to establish proof of efficacy and optimal dose of a new inhaled epithelial sodium channel inhibitor BI 1265162 in adults and adolescents with cystic fibrosis: BALANCE-CFTM 1. Issue 4 (7th December 2020) Authors: Goss, Christopher H.; Jain, Raksha; Seibold, Wolfgang; Picard, Anne-Caroline; Hsu, Ming-Chi; Gupta, Abhya; Fajac, Isabelle Journal: ERJ open research Issue: Volume 6:Issue 4(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Preclinical evaluation of the epithelial sodium channel inhibitor BI 1265162 for treatment of cystic fibrosis. Issue 4 (7th December 2020) Authors: Nickolaus, Peter; Jung, Birgit; Sabater, Juan; Constant, Samuel; Gupta, Abhya Journal: ERJ open research Issue: Volume 6:Issue 4(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗